We are monitoring the impact of COVID-19 on Latin America Therapeutic Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 60
Share on
Share on

Latin America Therapeutic Vaccines Market Research Report – Segmented By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) and Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 60
Pages: 138

Latin America Therapeutic Vaccines Market Size (2020 to 2025)

The Latin American Therapeutic Vaccines Market size is estimated to grow USD 1618.98 Million by 2025, from the current value of USD 361.06 Million in 2020, growing at a CAGR of 35% between 2020 to 2025.

In the pipeline, several approaches are being developed to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. Added to this, the vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features that increase the complexity of assessing and understanding pricing and procurement in their context.

Coming to Latin America, Sanofi Pasteur, the vaccines division of Sanofi, announced that Brazil had granted regulatory approval to Dengvaxia®, representing the third successful licensure of the dengue vaccine, which was also approved in Mexico and the Philippines earlier in 2015. This, because Brazil is the fifth most populated globally and first in Latin America, is plagued by 1.4 million dengue patients. The remaining countries in Latin America also have a natural threat as they lie in the tropical Amazon basin, making them a hotbed for various epidemics.

An increase in funding’s from the government for vaccine development, a rise in investments by the major market players, rising prevalence of the disease, technological advancements, initiatives by NGOs are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, and high costs associated with treatment are few factors inhibiting the market's growth.

This research report on the Latin American Therapeutic Vaccines Market segmented and sub-segmented into the following categories:

By Disease Type: 

  • Autoimmune Disease
  • Cancer
  • Neurological Disease
  • Infectious Disease

By Country: 

  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest of Latin America

Companies playing a notable role in the Latin American Therapeutic Vaccines Market covered in this report are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Analysis Design                                                         

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                           

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                      

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 By Disease Type                                                       

                                5.1.1 Autoimmune Disease Vaccines                                      

                                5.1.2 Cancer Vaccines                                    

                                                5.1.2.1 Multikine                             

                                                5.1.2.2 PR1 Peptide                        

                                                5.1.2.3 TroVax                  

                                                5.1.2.4 CYT004-MelQbG10                           

                                5.1.3 Neurological Disease Vaccines                                        

                                                5.1.3.1 ACC- 001                               

                                                5.1.3.2 CAD 106                

                                                5.1.3.3 Parkinson's Disease Vaccine                        

                                                5.1.3.4 Alzheimer's Disease                        

                                5.1.4 Infectious Disease Vaccines                                             

                                                5.1.4.1 Hepatitis C                           

                                                5.1.4.2 HIV/AIDS                              

                                                5.1.4.3 Other Infectious Disease                               

  1. Geographical Analysis

                6.1 Introduction                                                               

                6.2 Brazil                                                             

                6.3 Argentina                                                    

                6.4 Mexico                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 GlaxoSMithKline plc.                                                              

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Merck and Company                                                              

                8.3 Bavarian Nordic                                                        

                8.4 CSL Limited                                                 

                8.5 Emergent Biosolutions Inc.                                                  

                8.6 Novartis AG                                                

                8.7 Johnson and Johnson                                                            

                8.8 MedImmune LLC                                                     

                8.9 Pfizer Inc.                                                    

                8.10 Sanofi Pasteur                                                        

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Therapeutic Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  2. Latin America Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  3. Latin America Autoimmune Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  4. Latin America Cancer Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  5. Latin America Neurological Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  6. Latin America Infectious Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  7. Latin America Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  8. Latin America Multikine Market, By Region, From 2020 to 2025 (USD Million)
  9. Latin America PR1 Peptide Market, By Region, From 2020 to 2025 (USD Million)
  10. Latin America TroVax Market, By Region, From 2020 to 2025 (USD Million)
  11. Latin America CYT004-MelQbG10 Market, By Region, From 2020 to 2025 (USD Million)
  12. Latin America Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  13. Latin America ACC- 001 Market, By Region, From 2020 to 2025 (USD Million)
  14. Latin America CAD 106 Market, By Region, From 2020 to 2025 (USD Million)
  15. Latin America Parkinson's Vaccine Market, By Region, From 2020 to 2025 (USD Million)
  16. Latin America Alzheimer's Vaccine Market, By Region, From 2020 to 2025 (USD Million)
  17. Latin America Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  18. Latin America Hepatitis C Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  19. Latin America HIV/AIDS Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  20. Latin America Other Infectious Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  21. Brazil Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  22. Argentina Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  23. Mexico Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  24. Brazil Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  25. Argentina Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  26. Mexico Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  27. Brazil Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  28. Argentina Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  29. Mexico Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  30. Brazil Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  31. Argentina Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  32. Mexico Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample